June 6, 5:31 AM
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
May 16, 5:47 PM
Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.
May 9, 1:11 PM
SVB Leerink analyst Jonathan Chang maintains Adaptimmune Therapeutics (NASDAQ:ADAP) with a Market Perform and raises the price target from $2 to $3.
May 4, 5:58 AM
Adaptimmune Therapeutics (NASDAQ:ADAP) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.